Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CATCo launches traditional reinsurance fund

17 Mar 2014 12:32

RNS Number : 4751C
CATCo Reinsurance Opps Fund Ltd
17 March 2014
 



 

 

17 March 2014

 

PRESS RELEASE

CATCo launches its first traditional reinsurance strategy

 

CATCo Investment Management Ltd ("CATCo" or "the Company"), the Bermuda-based specialist insurance linked securities manager and advisors to the CATCo Group of Companies, announces the expansion of its investment product range to include the firm's first dedicated traditional reinsurance investment strategy, the Aquilo Fund ("Aquilo").

 

Managed by Tony Belisle, and co-managed by Charlie Vaughan and Rick Montgomerie, who recently joined CATCo as Directors of Underwriting, Aquilo will seek capital return over the short term, with an emphasis on the traditional reinsurance sector. The Fund will be exposed to traditional global reinsurance risk, insurance-linked securities (such as notes, swaps and other derivatives), and other financial instruments.

 

Aquilo, approved by the Bermuda Monetary Authority, will launch with initial capital of $110 million, with planned growth for 2015 to $250 million, and is CATCo's sixth fund launch since inception. The Aquilo focus will be on providing catastrophic protections to the underserved small to mid-sized global insurance community.

 

CATCo manages in excess of $2.5 billion, and in just three years has generated a market share of approximately 20 percent of the retrocessional market and built a strong brand presence.

 

Tony Belisle, Chief Executive Officer of CATCo Investment Management Ltd., said: 

 

"Within the CATCo Group of Companies there is a growing suite of products individually tailored to meet the different investment criteria for both CATCo's existing and potential investors."

 

"CATCo has a reputation for developing innovative solutions for its clients and we look forward to bringing our increasingly diversified investment strategies to the traditional reinsurance sector."

'Ends'

 

For further information, please contact:

 

Mark Way

Corporate Communications Director

CATCo Investment Management Ltd

Telephone: +44 7786 116991

mark.way@catcoim.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFUFEWFLSEED
Date   Source Headline
9th Jun 200612:36 pmRNSEPT Disclosure
9th Jun 200611:56 amRNSEPT Disclosure
9th Jun 200611:54 amRNSEPT Disclosure
9th Jun 200611:38 amRNSRule 8.3-Cambridge Antibody
8th Jun 20064:19 pmRNSRule 2.10 Announcement
8th Jun 20062:21 pmRNSEPT Disclosure
8th Jun 20061:14 pmRNSRule 8.3- (CAT)
8th Jun 200610:49 amRNSEPT Disclosure
7th Jun 20065:01 pmRNSHolding(s) in Company
7th Jun 20064:55 pmRNSRule 8.3- Cambridge Anti Tech
7th Jun 200612:38 pmRNSRule 8.3- (CAT)
7th Jun 200612:08 pmRNSEPT Disclosure
7th Jun 200610:00 amRNSOffer for Cambridge Antibody
6th Jun 20064:01 pmRNSRule 8.3- Cambridge Antibody
6th Jun 20063:45 pmRNSRule 8.3- Cambridge Antibody
6th Jun 200612:43 pmRNSEPT Disclosure
5th Jun 20066:00 pmRNSEPT Disclosure
5th Jun 20061:10 pmRNSRule 8.3- (CAT)
5th Jun 200612:55 pmRNSEPT Disclosure
5th Jun 200611:24 amRNSEPT Disclosure
2nd Jun 20062:14 pmRNSEPT Disclosure
2nd Jun 20061:19 pmRNSRule 8.3- (CAT)
2nd Jun 200612:27 pmRNSEPT Disclosure
2nd Jun 200612:22 pmRNSEPT Disclosure
2nd Jun 20067:00 amRNSRule 8.3- Cambridge Antibody
1st Jun 20064:22 pmRNSRule 8.3- Cambridge Antibody
1st Jun 20063:21 pmRNSHolding(s) in Company
1st Jun 200612:25 pmRNSEPT Disclosure
1st Jun 200611:10 amRNSEPT Disclosure
31st May 20063:13 pmRNSRule 8.3- (CAT)
31st May 20063:00 pmRNSMerger Update
31st May 20061:04 pmRNSRule 8.3- Cambridge Antibody
31st May 200611:43 amRNSEPT Disclosure
31st May 200611:27 amRNSEPT Disclosure
31st May 200611:25 amRNSEPT Disclosure
30th May 20063:25 pmRNSRule 8.3- (CAT)
30th May 20063:16 pmRNSEPT Disclosure
30th May 200611:49 amRNSEPT Disclosure
30th May 200610:29 amRNSEPT Disclosure
26th May 20062:26 pmRNSEPT Disclosure
26th May 20061:28 pmRNSRule 8.3- (CAT)
26th May 200611:20 amRNSEPT Disclosure
26th May 200610:55 amRNSEPT Disclosure
26th May 200610:05 amRNSRule 8.3- (CAT)
26th May 200610:03 amRNSRule 8.3- (CAT)
26th May 200610:02 amRNSRule 8.3- (CAT)
26th May 200610:00 amRNSRule 8.3- (CAT)
25th May 20063:49 pmRNSRule 2.10 Announcement
25th May 20061:09 pmRNSEPT Disclosure
25th May 200612:10 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.